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doi:10.1016/j.jtcvs.2006.06.018bjective: Paraplegia caused by spinal cord ischemia remains a serious complica-
ion after surgical repair of thoracoabdminal aortic aneurysms. Hepatocyte growth
actor is a potent angiogenic and neurotrophic factor. We sought to investigate the
europrotective effect of gene transfer of hepatocyte growth factor on spinal cord
schemia in rabbits.
ethods: Human hepatocyte growth factor expression plasmid was combined with
emagglutinating virus of Japan envelope vector. Hemagglutinating virus of Japan
nvelope vector containing the hepatocyte growth factor gene was injected intra-
hecally into the experimental rabbits, whereas control vector or saline was given to
he control animals. Five days later, spinal cord ischemia was induced by means of
nfrarenal aortic occlusion for 30 minutes. Hind-limb motor function was assessed
uring a 14-day recovery period with Tarlov criteria.
esults: Human hepatocyte growth factor was detected in the cerebrospinal fluid 3
ays after gene transfer, and the level peaked on day 5. Compared with the control
nimals, hepatocyte growth factor gene transfer significantly increased the capillary
ensity in the gray matter and decreased the spinal cord edema. All rabbits pretreated
ith saline or control vector had hind-limb paraplegia (Tarlov score 0) 14 days after
pinal cord ischemia. However, previous transfection of the hepatocyte growth
actor gene remarkably enhanced the Tarlov scores, and 8 of the 9 rabbits showed
ormal motor function (Tarlov score 5) after a 14-day recovery period. Histologic
xamination showed that the intact motor neurons were preserved to a much greater
xtent in the rabbits transfected with the hepatocyte growth factor gene.
onclusion: Gene transfer of hepatocyte growth factor attenuates neurologic injury
fter spinal cord ischemia.
araplegia that results from spinal cord ischemia remains a major devastating
and unpredictable complication after surgical repair of descending and tho-
racoabdominal aortic aneurysms. Regardless of the progress with surgical
echniques and pharmacologic interventions, this complication still cannot be pre-
ented completely.1,2
Therapeutic angiogenesis has been considered to be an effective way to treat
schemic disorders of the central nervous system (CNS). Neurons are highly
ensitive to ischemia, and transient ischemia can induce delayed neuronal death,
ven after recirculation. Therefore the simple effect of stimulation of angiogenesis
ight not be enough to treat CNS ischemia. An ideal therapeutic strategy to treat
schemic neurologic injury should have both aspects of enhancement of collateral
ormation and prevention of neuronal death. Recently, it has been demonstrated that
epatocyte growth factor (HGF) functions as a powerful angiogenic factor,3,4 as
ell as a potent neurotrophic factor,5,6 although HGF was originally identified from
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CSPlasma and serum as a molecule that could stimulate DNA
ynthesis in rat and human hepatocytes.7 HGF has been
eported to induce versatile neuroprotective effects both in
itro and in vivo,8-13 which has led to the hypothesis t
GF can be beneficial in treating neurologic disorders of
pinal cord ischemia. The aim of the present study was to
etermine whether prophylactic gene transfer of human
GF into the subarachnoid space by using hemagglutinat-
ng virus of Japan (HVJ) envelope vector can attenuate
eurologic injuries of spinal cord ischemia in a well-
haracterized rabbit model.
aterials and Methods
onstruction of Plasmids
uman HGF cDNA (2.2 kb) was inserted between the EcoRI and
otI sites of the pUC-Sr expression vector plasmid to produce an
GF expression vector. A pcDNA 3.1() plasmid DNA vector
ith the same structure but not containing HGF cDNA was used as
 control vector.11
reparation of HVJ Envelope Vector
VJ envelope vector was prepared as described previousl14
riefly, HVJ was purified by means of centrifugation and inacti-
ated by UV irradiation, which abolished the replication of the
irus completely but did not affect the cell membrane–fusing
apability of the envelope. HVJ envelope (20 AU) was mixed with
00 g of plasmid DNA and 0.3% Triton-X. After centrifugation,
he mixture was washed with 1 mL of balanced salt solution to
emove the detergent and unincorporated DNA. Then the envelope
ector was suspended in 400 L of phosphate-buffered saline, and
he suspension was stored at 4°C until use.
nimal Care and Surgical Procedure
apanese white rabbits weighing 1.8 to 2.4 kg were used in the
tudy. The animal protocol was approved by the Ethics Review
ommittee for Animal Experimentation of Hamamatsu University
chool of Medicine and was in accordance with the National
nstitutes of Health “Guide for the care and use of laboratory
nimals.” Spinal cord ischemia was induced by infrarenal aortic
cclusion, according to the method described previously.15
n Vivo Gene Transfer and Experimental Protocol
he intervertebral space between L5 and L6 was punctured with a
6-gauge needle, and polyethylene-10 tubing was inserted through
t into the subarachnoid space. The desired position of the catheter
Abbreviations and Acronyms
CNS  central nervous system
CSF  cerebrospinal fluid
HGF  hepatocyte growth factor
HVJ  hemagglutinating virus of Japan
VEGF  vascular endothelial growth factor
VSMC vascular smooth muscle cellas confirmed by means of cautious aspiration of cerebrospinal i
42 The Journal of Thoracic and Cardiovascular Surgery ● Octouid (CSF).16 After removal of 400 L of CSF, saline (400 L),
VJ envelope vector (400 L) containing pcDNA 3.1(), or
uman HGF plasmid DNA was carefully injected into the saline
roup (n  7), control vector group (n  7), or HGF group (n  9),
espectively. The animals were included in the study only if they
ad normal hind-limb motor function after intrathecal injection.
ive days later, all rabbits were subjected to 30 minutes of spinal
ord ischemia.
easurement of Human HGF Concentration in CSF
ne hundred microliters of CSF was collected before gene transfer
nd 3, 5, 12, and 19 days after gene transfer. The concentration of
GF in the CSF was determined by means of enzyme immuno-
ssay with an anti-human HGF antibody (Institute of Immunology,
okyo, Japan), which reacts only with human HGF but not with
abbit HGF.10,12
eurologic Assessment
uring a 14-day recovery after ischemia, hind-limb motor function
as assessed by 2 blinded observers using the modified Tarlov
cale17: 0, no movement; 1, slight movement; 2, sit with -
ance; 3, sit alone; 4, weak hop; 5, normal hop.
uantification of Capillary Density
dditional rabbits (n  5 for each group) were killed just before
pinal cord ischemia to analyze the angiogenic effect of HGF gene
ransfer in the spinal cord. Alkaline phosphatase staining was used
s a specific marker of endothelial cells in paraffin-embedded
ections (10  m).10 The number of microvessels in the ven
ray matter was counted by a blinded investigator. Three indi-
idual sections from the lumbar spinal cord (L4-L6) were
nalyzed.
valuation of Spinal Cord Edema After
ransient Ischemia
n a parallel series of experiments (n  5 for each group), spinal
ords were collected from rabbits 24 hours after ischemia. Spinal
ords were divided into ischemic segments (lumbar spinal cords,
4-L6) and nonischemic segments (thoracic spinal cords, T8-T10).
he wet weight was measured quickly, and then the spinal cord
as dried in an oven at 110°C for 24 hours. The water content was
alculated as follows:
Water content (%) (Wet weight Dry weight)
 100 ⁄ Wet weight.12
istologic Study
ll animals of the 3 groups were killed 14 days after the transient
schemia. Paraffin-embedded sections (4 m) of lumbar spinal
ords (L4-L6) were stained with hematoxylin and eosin. In cases
n which the cytoplasm was diffusely eosinophilic, the large motor
euron cells were considered to be necrotic or dead. When the cells
emonstrated basophilic stippling (containing Nissl substance), the
otor-neuron cells were considered to be viable or alive.18 Thentact motor neurons in the ventral gray matter were counted by a
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Plinded investigator in 3 sections for each rabbit, and the results
ere then averaged.
tatistical Analysis
alues were expressed as means  standard deviation. The Kruskal-
allis test for nonparametric values and analysis of variance with the
ubsequent Duncan test for parametric values were used.
esults
uman HGF Expression
uman HGF protein was readily detected in the CSF of
abbits transfected with human HGF vector 3 days after
ransfection but not before transfection (Figure 1). 
xpression level peaked on day 5 and then dropped off
radually. Human HGF still could be detected 19 days after
ene transfection. However, no such expression could be
etected in animals that received saline or control vector at
ny defined time point.
ngiogenesis Induced by HGF Gene Transfer
he microvessels in the spinal cord of rabbits transfected
ith the HGF gene showed a more complex pattern than
hose of rabbits pretreated with saline or control vector 5
ays after transfection (Figure 2, A). Consistently, transfec
ion of the HGF gene significantly increased the capillary
ensity in the ventral gray matter compared with that seen in
nimals pretreated with saline or control vector (P  .01,
espectively; Figure 2, B).
ater Content After Spinal Cord Ischemia
wenty-four hours after transient infrarenal aortic occlu-
igure 1. Concentration of human hepatocyte growth factor
HGF) protein in cerebrospinal fluid before transfection and 3,
, 12, and 19 days after transfection. Saline, Rabbits pretreated
ith intrathecal injection of saline; control vector, rabbits
ransfected with control vector; HGF, rabbits transfected with
uman HGF vector.ion, the ischemic spinal cord of the 3 groups contained i
The Journal of Thoracicore water than the corresponding nonischemic segments
Figure 3). Compared with the rabbits pretreated with s
nd control vector, the water content in the ischemic spinal
ords of rabbits transfected with human HGF was signifi-
antly decreased (P  .05, respectively).
eurologic Assessment
he individual neurologic scores of the 3 groups before
schemia and 1, 2, 7, and 14 days after ischemia are shown
n Figure 4. All rabbits showed normal hind-limb m
unction after intrathecal injection and before the induction
f ischemia (Tarlov score  5). A 30-minute period of
nfrarenal aortic occlusion resulted in severe lower-
xtremity neurologic deficits in the rabbits pretreated
ith saline and control vectors, in which all rabbits
howed complete paralysis (Tarlov score  0) after the
4-day observation period. Although evidence of early
eurologic injury was found 1 day after ischemia, previ-
us transfection of the HGF gene remarkably enhanced
he recovery of motor function, and 8 of the 9 rabbits
howed normal motor function 14 days later (compared
ith the Tarlov scores of the saline and control vector
roups, P  .01, at each of the 4 time points after
igure 2. Angiogenic effects of transfection of human hepatocyte
rowth factor (HGF) gene on the spinal cord 5 days after trans-
ection. A, Representative cross-sections. (Original magnification
00.) B, Number of vessels in the ventral gray matter of the
pinal cord. Saline, Rabbits pretreated with intrathecal injection
f saline; control vector, rabbits transfected with control vector;
GF, rabbits transfected with human HGF vector.schemia, respectively).
and Cardiovascular Surgery ● Volume 132, Number 4 943
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CSPistologic Assessment
our rabbits that underwent a sham operation were also en-
olled in the histologic study. Representative sections stained
ith hematoxylin and eosin are shown in Figure 5, A, and th
esults of counting viable motor neurons are summarized in
Figure 4. Neurologic function assessed just before spina
represent individual rabbits. Saline, Rabbits pretreated
transfected with control vector; HGF, rabbits transfected with
44 The Journal of Thoracic and Cardiovascular Surgery ● Octoigure 5, B. In the sham-operated animals the spinal cord 
ntact, and many large motor neurons were present in the
nterior horn. A 30-minute aortic occlusion induced severe
euronal damage in the animals pretreated with saline and
ontrol vector 14 days after ischemia, as evidenced by means
ischemia and 1, 2, 7, and 14 days after ischemia. Cycles
intrathecal injection of saline; control vector, rabbits
Figure 3. Water content of the
spinal cord 24 hours after tran-
sient ischemia. Saline, Rabbits
pretreated with intrathecal in-
jection of saline; control vector,
rabbits transfected with control
vector; HGF, rabbits transfected
with human hepatocyte growth
factor (HGF) vector.l cord
withhuman hepatocyte growth factor (HGF) vector.
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Pf vacuolization, frank necrosis, and an almost total loss of
he motor neurons. No significant difference in the motor
euron count was found between the saline and control
ector groups (P  .05). In contrast, only slight histologic
hanges were found in the lumbar spinal cords of animals
hat received HGF gene transfer, and most of the motor
eurons remained intact (P  .01 versus both the saline and
ontrol vector groups, respectively).
iscussion
pinal cord ischemia discussed in the present study is a
omplication of surgical intervention, and the exact time of
ts occurrence can be known. Therefore precautionary mea-
ures to protect the spinal cord are necessary and feasible.
e have tried a novel prophylactic strategy to prevent
igure 5. Histologic assessment of the spinal cord 14 days after
ransient ischemia. A, Representative sections of lumbar spinal
ords stained with hematoxylin and eosin. (Original magnifica-
ion 100.) HGF, Hepatocyte growth factor. B, Number of large
otor neurons in the ventral gray matter. Saline, Rabbits pre-
reated with intrathecal injection of saline; control vector, rabbits
ransfected with control vector; HGF, rabbits transfected with
uman hepatocyte growth factor (HGF) vector.pinal cord injury in the current study, and the data dem- t
The Journal of Thoracicnstrate the following: (1) gene transfer into the spinal cord
an be performed successfully by means of intrathecal in-
ection of HVJ envelope vector containing HGF expression
lasmid, (2) overexpression of the HGF gene induces an-
iogenesis in the spinal cord and reduces spinal cord edema
fter ischemia, and (3) previous transfection of the HGF
ene significantly attenuates neurologic deficits caused by
pinal cord ischemia.
HGF is a well-known pleiotropic cytokine that exhibits
itogenic and morphogenic activities toward a variety of
ells, including endothelial cells.19 The mitogenic activity
f HGF in endothelial cells was reported to be even more
otent than that of vascular endothelial growth factor
VEGF).20 Therefore, HGF has been identified as a poten
ngiogenic factor. In vivo evidences demonstrate that HGF
timulates angiogenesis with increase of blood flow in var-
ous tissues, such as myocardium,21 skeletal muscle,17 and
rain.10,12 Moreover, HGF also plays a role as a neur-
hic and survival factor to maintain the physiologic struc-
ure and function of the nervous system. Both HGF and
-Met, an HGF receptor of membrane-spanning tyrosine
inase, are expressed in various regions of the brain5 nd
eripheral neurons.22 Functional coupling between HG
nd c-Met enhances the survival of hippocampal neurons
n primary culture and induces neurite outgrowth in neu-
 o nal development in vitro.23 Sensory and sympathetic neu-
ons and their precursors respond to HGF with increased
ifferentiation, survival, and axonal outgrowth.24 HGF is
xpressed in the brain in the early phase after cerebral
schemia25 and induces a neuroprotective effect agai
ostischemic delayed neuronal death in the hippocampu26
n cerebral artery occlusion models HGF has been re-
orted to induce therapeutic angiogenesis, improve blood
ow, reduce the infarct volume, and attenuate neurologic
njuries,10,12,13 which demonstrates that HGF possesses
otential therapeutic value for CNS ischemia. It is plau-
ible that HGF secreted from transfected cells induces the
owerful neuroprotective effects observed in the current
tudy through its angiogenic and neurotrophic activities.
However, the short serum half-life of the recombinant
rotein limits the therapeutic value of HGF. Gene transfer
ppears to have advantages over the administration of single-
r multiple-bolus doses of a recombinant protein because it
an achieve an optimally high local concentration of protein
ithin the nervous system.10-12 In the study by Yoshimu
nd colleagues,10 gene transfer of HGF markedly increas
he cerebral blood flow in the ischemic brain, whereas single
njection of recombinant HGF failed to do so. For gene
ransfer to the spinal cord, a nonviral HVJ envelope–medi-
ted method was used in the current study. Although viral
ectors are always used to transfer gene into nervous system
or their high transfection efficiency, these vectors are poten-
ially hazardous because of cointroduction of genetic elements
and Cardiovascular Surgery ● Volume 132, Number 4 945
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CSProm parent viruses, leaky expression of viral genes, immuno-
enicity, and changes in the host genome.27 Nonviral vectors
re less toxic and less immunogenic. HVJ envelope is a puri-
ed vesicle prepared from HVJ, the replication activity and
nfectivity of which have been completely inhibited,
hereas the activities of the 2 envelope proteins (hemag-
lutinating neuroaminidase and fusion protein) are main-
ained almost at the same levels as those of live HVJ. This
ector has been used to transfer gene into various tissues
uccessfully, including nervous system tissue.12,14 Another
ifficulty for gene transfer to the spinal cord is the presence
f the blood-brain barrier, which makes the spinal cord
elatively inaccessible to circulating proteins and peptides.
ntrathecal injection through lumbar puncture might be a
easible method to overcome this limitation. Our previous
tudy shows that lumbar puncture can be readily performed
ithout severe invasion.16 In the present study the hum
GF gene was transferred into rabbit spinal cords by means
f intrathecal injection. Secretion of HGF from the trans-
ected cells was still detected in the CSF more than 2 weeks
fter transfection. On the other hand, the blood-brain barrier
ight also ensure that other organs except CNS are not
ransfected when gene transfer is performed through intra-
hecal injection.
VEGF, another important angiogenic factor, also has
europrotective effects. However, administration of recom-
inant VEGF to the ischemic brain has been reported to
ncrease cerebral edema, which was provoked in part by
nhanced cerebrovascular permeability.28 Similarly, lower-
imb edema was reported as a side effect after gene transfer
f VEGF into the ischemic limb.29 In contrast to thes
ndings, gene transfer of HGF did not augment spinal cord
dema in the current study. Indeed, the water content of the
schemic spinal cord was decreased after transfection of the
GF gene. Consistent with our data, overexpression of
GF did not exacerbate cerebral edema and destruction of
he blood-brain barrier in the ischemic brain.12 The differ-
nce in effects of HGF and VEGF on vascular smooth
uscle cells (VSMCs) might be the explanation for the
ivergent edema formation between HGF and VEGF. HGF
timulates the migration of VSMCs without their multipli-
ation,20 whereas VEGF has no effect on either the m-
ion or the proliferation of VSMCs because of the lack of
EGF receptors on VSMCs.30 Thus angiogenesis induced
y VEGF is featured as a delay in the maturation of blood
essels. However, because HGF simultaneously stimulates
he migration of both endothelial cells and VSMCs, the
lood vessels might mature in a well-coordinated way at an
arlier time, thereby avoiding the release of blood-derived
ells into the extracellular space.30 To this point, HGF mig
e better to treat CNS ischemia.
In conclusion, our study demonstrates for the first time
hat intrathecal injection of nonviral HVJ envelope–based
46 The Journal of Thoracic and Cardiovascular Surgery ● Octoector is efficient in transferring the gene of interest into the
pinal cord and that prophylactic gene transfer of HGF
nduces powerful neuroprotective effects against spinal cord
schemia. Our observations expand the understanding of the
europrotective properties of HGF. Although the current
ata are not advanced enough for human gene therapy, the
roofs still suggest that gene transfer of HGF might be a
ovel therapeutic strategy to prevent neurologic injury after
horacic aneurysm surgery.
We thank AnGes MG Inc, Osaka, Japan, for providing the
aked plasmid encoding HGF.
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